Although the use of immunotherapy to treat cancer was once a far-fetched idea, the method has been gaining more traction lately.
A feature published July 30 in the New York Times explores how immunotherapy is being used to destroy tumors and cure terminal illnesses. It helps the immune system recognize cancer and defend itself by attacking it.
The method, which is backed by legitimate, credible data, is leading to a significant increase in the resources and research going into it.
If immunotherapy continues to relay positive results, chemotherapy and radiation could become a treatment of the past.
To read more about immunotherapy, click the link below.
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.